Standard BioTools Return on Tangible Equity 2010-2024 | LAB

Current and historical return on tangible equity values for Standard BioTools (LAB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Standard BioTools Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.17B $0.36B -55.12%
2024-06-30 $-0.17B $0.38B -69.47%
2024-03-31 $-0.14B $0.45B -83.05%
2023-12-31 $-0.08B $0.06B -97.72%
2023-09-30 $-0.08B $0.07B -83.75%
2023-06-30 $-0.08B $0.09B -79.81%
2023-03-31 $-0.13B $0.10B -108.04%
2022-12-31 $-0.19B $0.11B -273.38%
2022-09-30 $-0.18B $0.13B -560.63%
2022-06-30 $-0.16B $0.15B 1715.79%
2022-03-31 $-0.12B $-0.11B 212.84%
2021-12-31 $-0.06B $-0.04B 181.54%
2021-09-30 $-0.07B $-0.04B 277.55%
2021-06-30 $-0.06B $-0.03B 421.05%
2021-03-31 $-0.06B $-0.02B 497.78%
2020-12-31 $-0.05B $-0.01B 572.97%
2020-09-30 $-0.05B $0.00B 738.46%
2020-06-30 $-0.06B $-0.02B 1100.00%
2020-03-31 $-0.06B $-0.01B -1400.00%
2019-12-31 $-0.07B $0.00B -490.57%
2019-09-30 $-0.07B $0.01B 687.18%
2019-06-30 $-0.07B $0.02B 145.26%
2019-03-31 $-0.07B $0.02B 83.78%
2018-12-31 $-0.06B $-0.09B 48.76%
2018-09-30 $-0.05B $-0.14B 40.22%
2018-06-30 $-0.06B $-0.13B 41.43%
2018-03-31 $-0.06B $-0.12B 40.51%
2017-12-31 $-0.06B $-0.14B 41.74%
2017-09-30 $-0.07B $-0.14B 48.23%
2017-06-30 $-0.07B $-0.15B 52.65%
2017-03-31 $-0.07B $-0.14B 59.44%
2016-12-31 $-0.08B $-0.13B 68.75%
2016-09-30 $-0.07B $-0.12B 72.54%
2016-06-30 $-0.06B $-0.11B 69.32%
2016-03-31 $-0.06B $-0.09B 72.61%
2015-12-31 $-0.05B $-0.08B 75.18%
2015-09-30 $-0.05B $-0.07B 79.07%
2015-06-30 $-0.06B $-0.07B 93.72%
2015-03-31 $-0.05B $-0.06B 97.30%
2014-12-31 $-0.05B $-0.06B 101.92%
2014-09-30 $-0.05B $-0.06B 335.71%
2014-06-30 $-0.04B $-0.05B -154.17%
2014-03-31 $-0.03B $-0.05B -45.90%
2013-12-31 $-0.02B $0.10B -17.39%
2013-09-30 $-0.02B $0.10B -16.16%
2013-06-30 $-0.02B $0.10B -15.92%
2013-03-31 $-0.02B $0.10B -19.26%
2012-12-31 $-0.02B $0.10B -26.23%
2012-09-30 $-0.02B $0.10B -29.12%
2012-06-30 $-0.02B $0.05B -35.02%
2012-03-31 $-0.02B $0.05B -36.52%
2011-12-31 $-0.03B $0.06B -50.20%
2011-09-30 $-0.03B $0.06B -12400.00%
2011-06-30 $-0.03B $0.06B 200.00%
2011-03-31 $-0.03B $0.07B 91.80%
2010-12-31 $-0.02B $-0.19B 35.60%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.562B $0.106B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00